InvestorsHub Logo
Followers 53
Posts 3357
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 2641

Sunday, 08/11/2019 10:04:20 PM

Sunday, August 11, 2019 10:04:20 PM

Post# of 3283

I know, I know


Well, I knew I knew it. I dunno why I bothered.

I’m feeling a lot of negativity towards Spectrum right now w their timelines. They earned it from their Rolontis guidance last year. Around this time in 2017, they were indicating Rolontis BLA filing in the 2nd half of 2018, and then later on it changed to 4th Q 2018, and then they filed it in the last week of Dec 2018. I believe they knew all along that it wasn’t going to be filed till Dec to let safety data mature, at least that’s my belief. If they knew they were going to file in Dec wouldn’t it have been better to tell us that? It was like we were being played by them. So, they lost a lot of credibility in my book for not being more forthcoming. Now they tell us both the Rolontis BLA filing and pozi cohort one topline will come in the 4th Q. From there past actions, I have to think those PRs won’t come till Dec. It would be nice if it’s Sept for Rolontis i.e. 6 months after they withdrew the BLA but how can you expect that? I can’t expect it based on past actions but I hope it happens in Sept. Regarding pozi, it’s a double edge sword. The longer the wait, the better the expectation of better results especially DoR that’s why I was hoping for interim results before topline. In a previous post, I gave an example of a biotech releasing relatively mature ORR but waiting on DoR. That’s what I was hoping Spectrum would do and was wondering if they were doing it to keep the share price down. Anyhows, unless some significant news is PR’d I am shutting my trap till topline.